Skip to main content
. 2022 Mar 17;17(3):e0264785. doi: 10.1371/journal.pone.0264785

Fig 7.

Fig 7

Biomarker variations in different patient classes in due course of disease progression by (A) risk (B) mortality parameters. Showing consistent separation of biomarker levels in mortality prediction parameters and a decrease in separation of risk prediction parameters.